A Roadmap to Compassion○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
○
The Implementation of a Working
Medicinal Cannabis Program in Canada
By the Canadians for Safe Access,
the B.C. Compassion Club Society, and the
Victoria Island Compassion Society:
Philippe Lucas, Hilary Black, and Rielle Capler
02/18/04
Roadmap to Compassion
The Implementation of a WorkingMedicinal Cannabis Program in Canada
○ ○ ○ ○ ○ ○ ○ ○ ○○ ○ ○ ○ ○ ○ ○
2
The Implementation of a Working Medicinal
Cannabis Program in Canada:
A Roadmap toCompassion
02/18/04
By Philippe Lucas, Hilary Black,
and Rielle Capler
For over five years, the Canadian federal
government has been struggling with the
development and implementation of a national
medicinal marijuana program. Although Health
Canada has taken some progressive policy steps,
many improvements are still needed.
This document identifies many of the roadblocks
Canadians have been facing with the MMAR
program, and proposes solutions to overcoming
them. These solutions focus on the already existing
and successful medical cannabis distribution
system in Canada, the compassion societies.
The courts have acknowledged that compassion
societies have been filling in the holes left by
Health Canada’s inadequate program. Many
government bodies, including the Senate Special
Committee on Illegal Drugs, the Ontario Court of
Appeals and the BC Provincial Court have also
recognized the key role of the Compassion
Societies in a viable national program.
Roadmap to Compassion
The Implementation of a WorkingMedicinal Cannabis Program in Canada
○ ○ ○ ○ ○ ○ ○ ○ ○○ ○ ○ ○ ○ ○ ○
3
From the Ontario Court ofAppeal in regards to theHitzig Decision:
“A central component of theGovernment’s case is that there isan established part of the blackmarket, which has historicallyprovided a safe source ofmarihuana to those with themedical need for it, and that there istherefore no supply issue. TheGovernment says that these“unlicensed suppliers” shouldcontinue to serve as the source ofsupply for those with a medicalexemption. Since our remedy ineffect simply clears the way for alicensing of these suppliers, theGovernment cannot be heard toargue that our remedy isunworkable.”
○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○
○ ○ ○ ○ ○ ○ ○ ○ ○○ ○ ○ ○ ○ ○ ○
Senate Special Committeeon Illegal Drugs
Conclusions of Chapter 9:
· People who smoke marijuana for therapeutic purposes preferto have a choice as to methods of use;
· Measures should be taken to support and encourage thedevelopment of alternative practices, such as theestablishment of compassion clubs;
· The practices of these organizations are in line with thetherapeutic indications arising from clinical studies and meetthe strict rules on quality and safety;
· The qualities of the marijuana used in those studies mustmeet the standards of current practice in compassion clubs,not NIDA standards;
· The studies should focus on applications and the specificdoses for various medical conditions;
· Health Canada should, at the earliest possible opportunity,undertake a clinical study in cooperation with Canadiancompassion clubs.
Roadmap to Compassion
The Implementation of a WorkingMedicinal Cannabis Program in Canada
○ ○ ○ ○ ○ ○ ○ ○ ○○ ○ ○ ○ ○ ○ ○
4
Problems with the MMAR
The Canadian government was ordered by the courts to amend the cannabis
prohibition laws to allow Canadians in medical need to access cannabis without
fear of legal repercussion. The response was the creation of the MMAR. Since
its implementation over 5 years ago, Health Canada’s medicinal cannabis
program has completely failed to live up to its mandate. Numerous courts
have found both the MMAR and its predecessor, the Section 56 Exemption,
unconstitutional. More tellingly, the critically and chronically ill Canadians who
have been diligent and determined enough to join the MMAR have also been
its most vocal and vociferous critics.
Obstacles to Access
While Health Canada’s own polls suggest that over 400,000 Canadians currently
claim to use cannabis for medicinal purposes, its program has registered a
mere 700 applicants over 4 years. Unjustified bureaucratic obstacles to
accessing the program, such as yearly renewals and the requirements of support
from a medical specialist, have created an oxymoron out of Health Canada’s
Office of Cannabis Medical Access.
Both the Canadian Medical Association and the Canadian Medical Protection
Association have issued notices to the medical community instructing them
not to participate in the federal medicinal cannabis program for fear of potential
legal liability. This has effectively stymied the proper implementation of the
MMAR.
A centralized approval and registration system is in itself an unnecessary
obstacle to access. Such a system is far more extensive, expensive, and difficult
to administer and enforce than regulations for any other medicine. Cannabis
simply does not warrant such restrictive and invasive measures.
Supply and Distribution
Once a patient has obtained an MMAR license, their choices for accessing a
legal supply are severely limited. They may either produce it themselves or
apply to have a third party grow for them. Many patients are not able to produce
their own medicine nor do they have feasible options for a third party-grower.
Roadmap to Compassion
The Implementation of a WorkingMedicinal Cannabis Program in Canada
○ ○ ○ ○ ○ ○ ○ ○ ○○ ○ ○ ○ ○ ○ ○
5
A more recent court-ordered option provides for license holders to apply to
receive their cannabis directly from Prairie Plant System. This half-hazard
option is problematic for several reasons:
· Health Canada’s attempts to produce medicinal grade cannabis have
been an embarrassing and expensive ($5 million +) failure, resulting
in a non-organic product that is of poor quality and potentially
dangerous to medicinal users. The product may be unsafe due to
heavy metal contamination and the use of gamma irradiation. Even
those who so desperately need this herb have rejected the product;
· The undeniable importance of making a variety of different strains of
cannabis products available in many different forms has been
ignored;
· A monopoly on production prevents the potential benefit to
medicinal cannabis users from the reduced cost, increased quality
and wider range of varieties that would prevail with free-market
competition;
· Current distribution possibilities completely ignore the educational
component necessary for the safe and successful use of cannabis
products.
Most importantly, the costs of this medicine are not yet covered. The price of
medicinal cannabis is artificially inflated due to its illegal status. As with other
prescribed medicines, cannabis should be covered through the provincial health
insurance system.
Research
Although Health Canada claims to be promoting research into this area of
medicine, it has only approved and fully funded one clinical protocol since the
implementation of this program. Experts in the field of medicinal cannabis are
concerned about skewed research outcomes resulting from the government’s
crop, which is below average quality cannabis.
In addition, Health Canada has inexplicably ignored the recommendations of
the Special Senate Committee to undertake research in collaboration with the
compassion societies.
Roadmap to Compassion
The Implementation of a WorkingMedicinal Cannabis Program in Canada
○ ○ ○ ○ ○ ○ ○ ○ ○○ ○ ○ ○ ○ ○ ○
6
Recommendations:A Roadmap for Change
What is readily apparent to all is that for a cost of over $3 million a year,
Canadians who could benefit from the use of medicinal cannabis are being
drastically underserved by the OCMA.
The following recommendations are based on the experience and expertise of
medicinal cannabis users and distributors, and are intended to:
· Help Health Canada finally address its many court obligations as
well its responsibilities to Canada’s critically and chronically ill;
· Put in place a community-based system for the safe and effective
non-profit cultivation and distribution of medicinal cannabis.
· Create a system that is easier to understand and implement - for
both patients and physicians - than the current system.;
· Allow Health Canada to use its resources more effectively and thus
reduce costs;
· Financially support patients in accessing their supply of medicine;
· Create a program that is both in line with Canada’s Constitution,
Canada’s international obligations that merits the support of the
Canadian courts, press, and public;
· Create a well funded research program using high quality cannabis;.
· And address concerns about black-market re-distribution.
The Role of Health Canada
Health Canada must abandon its role in the approval process of potential
medicinal cannabis users. This role creates a burden of wasted time and
unnecessary bureaucracy for applicants; and of expense and wasted resources
for Health Canada.
Health Canada should allow access to medicinal cannabis solely with a
confirmation of diagnosis from an appropriate health practitioner Physicians
are currently able to prescribe many controlled substances that are addictive
and potentially dangerous without onerous government oversight; there simply
is no logical or scientific reason to place cannabis under a stricter regulatory
regime. Although the effectiveness of cannabis in treating certain ailments
may not yet be fully conclusive, its remarkable safety profile is well established
and accepted within the scientific community.
Roadmap to Compassion
The Implementation of a WorkingMedicinal Cannabis Program in Canada
○ ○ ○ ○ ○ ○ ○ ○ ○○ ○ ○ ○ ○ ○ ○
7
○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○
○ ○ ○ ○ ○ ○ ○ ○ ○○ ○ ○ ○ ○ ○ ○
In order to ensure the success of this program, The OCMA’s role should more
closely resemble the Dutch Office of Medicinal Cannabis. Its roles would include:
· Working with provincial health care programs to ensure cost
coverage of medicinal cannabis and harm reduction devices such as
vaporizers, and for cultivation equipment where applicable;
· Creating national standards in collaboration with the existing
Compassion Societies for the operation and licensing of community-
based cannabis distribution centres;
· Establishing guidelines for site inspections and the testing of
cannabis for strength and safety;
· Creating system to ensure protection of medicinal cannabis users
from police interference;
· Providing appropriate information to consumers, healthcare
providers, and law enforcement.
The Role of Physicians and other HealthCare Practitioners
Health Canada should reconsider the role of the physician in the context of this
program. The Senate Special Committee on Illegal Drugs recognized some of
the concerns with prescribing an illegal herbal medication, but concluded that
these can be addressed by replacing the role of the physician as gatekeeper
with that of diagnostician:
“ The involvement of physicians in the process is not questioned – what must
be determined is their proper role with respect to use of cannabis for therapeutic
purposes. Physicians are trained to provide a diagnosis of a person’s medical
conditions and symptoms and to determine how to treat these conditions and
symptoms medically. Most do not have, however, adequate knowledge of the
therapeutic benefits of cannabis and are reluctant to associate themselves with
this product for a variety of reasons, including its illegality.
In these circumstances, the proper role of the physician should be to make a
diagnosis of the patient’s medical conditions or symptoms. If the condition or
symptom is one where cannabis has potential therapeutic applications, the
patient would be authorized to use the therapeutic product of his or her choice,
including cannabis. This would also mean eliminating the current requirement
that all other “”conventional treatments” have been tried or considered before
the use of cannabis is authorized. There is no justification for making cannabis
an option of “last resort.”
The involvement of physiciansin the process is notquestioned – what must bedetermined is their proper rolewith respect to use of cannabisfor therapeutic purposes.
Roadmap to Compassion
The Implementation of a WorkingMedicinal Cannabis Program in Canada
○ ○ ○ ○ ○ ○ ○ ○ ○○ ○ ○ ○ ○ ○ ○
8
These recommendations mirror the procedures already being carried out by
physicians in order to register their patients at Compassion Societies.
Compassion Societies require health care practitioners to confirm their patients’
diagnoses and symptoms, and to “recommend” rather than prescribe cannabis.
Any patient who has a confirmation of any condition or symptom for which
cannabis is an effective treatment should have the right to choose to utilize this
medicine within the health care system without further authorization. The decision
to use medicinal cannabis should be between a patient and their healthcare
practitioner, as it is with all pharmaceutical and natural health products.
Cannabis is an herb; therefore the authorization to recommend access must be
given to those health care practitioners most experienced with herbal medicine
and should not be limited to allopathic physicians. The BC Compassion Club
Society currently accepts confirmations of diagnosis and recommendations from
physicians (GP or specialist), Naturopathic Doctors, or Doctors of Traditional
Chinese Medicine. Clinical Herbalists will be added to this list once they have the
licensing bodies and associations necessary to be legally regulated.
The Role of the Compassion Societies
In the state of California, where over 70,000 registered users gain legal access
solely through compassion clubs, a recent Field poll suggests that support for
the program has grown from about 56% in 1996, to 74% today.
The compassion societies have been successfully meeting the needs of
medicinal cannabis users across the country for seven years. These not-for-
profit compassion societies currently supply over 6000 critically and chronically
ill Canadians with a safe supply of cannabis at no cost to Health Canada or the
taxpayers. They have been risking arrest, criminal records and imprisonment
for this important work.
Compassion societies have long ago recognized that different conditions
respond better to different varieties of cannabis and modes of administration.
They therefore stock numerous strains and offer this medicine as loose-leaf
product, or in the form of tinctures, oral sprays, edible oils, concentrates and
baked goods.
Similar to Health Canada’s program, compassion societies oversee membership
requirements, confirm diagnoses and recommedations with approved health
care practitioners and keep careful files on each member, tracking their use of
cannabis.
Roadmap to Compassion
The Implementation of a WorkingMedicinal Cannabis Program in Canada
○ ○ ○ ○ ○ ○ ○ ○ ○○ ○ ○ ○ ○ ○ ○
9
There are many additional services provided which are outside of
Health Canada’s mandate:
· Education regarding harm reduction strategies and information on
strains, proper dosages and methods of ingestion;
· A community environment, providing valuable social support and
safe space;
· Low cost complimentary healthcare, such as herbalism, counselling,
acupuncture, nutritional counselling, massage and yoga;
· Outreach designed to address the questions and concerns of
physicians and of law enforcement officials;
Under a new regulatory and licensing regime, the role of Compassion Societies
would remain much the same. Compassion Societies would continue to be
responsible for maintaining transparency and for accurate and accountable
record keeping. The Vancouver Island Compassion Society and the BC
Compassion Society are successful socially accepted and integrated models
of such organizations.
The Role of Private Cultivators
Sensibly regulated, not-for-profit organic cultivation of cannabis would allow a
safe and steady supply of medicine. Community based cultivation would take
advantage of the extensive genetic pool and knowledge residing within those
currently engaged in the grey-market production and distribution of therapeutic
cannabis. This would significantly improve the quality, expand the selection
and lower the cost of the supply.
Furthermore, it would relieve the federal government of the onerous and clearly
unwanted responsibility cultivating a Canadian supply of therapeutic cannabis.
Criteria for the licensing of compassion societiesand community-based cultivators:
An excellent guidance document for the regulation of the services provided by
compassion societies titled “Operational Standards for the Distribution of
Medicinal Cannabis” has been drafted by the British Columbia Compassion
Club Society - Canada’s oldest and largest compassion club - and should be
used as the basis for the development and implementation of further
regulations1 .
Roadmap to Compassion
The Implementation of a WorkingMedicinal Cannabis Program in Canada
○ ○ ○ ○ ○ ○ ○ ○ ○○ ○ ○ ○ ○ ○ ○
10
Some recommended standards are:
· Non-profit incorporation to guarantee financial transparency and
ensure responsibility to the consumer;
· A minimum level of production and distribution standards based on
Good Lab Practices (GLP) and Good Agricultural Practices (GMP)
guidelines;
· The exclusive use of organic cultivation practices;
· Participation in inspections to ensure standards are being met.
Compassion Society-Based Research
Compassion societies are uniquely suited to participate in research projects.
They have extensive experience in the application of cannabis as a medicine,
and their collective national membership are an untapped resource of potential
study participants.
Over the last 2 years, compassion societies have been at the forefront of
research into the safety and effectiveness of medicinal cannabis. They have
conducted research protocols regarding the effects of cannabis on Hep-C with
the University of California San Francisco and regarding nausea and pregnancy
with UBC. The VICS has received independent funding to study the effects of
smoked cannabis on chronic pain. All of this research is peer-reviewed and
publishable, and is being conducted at no cost to the taxpayer.
Health Canada must expanded its research agenda and funding to include
compassion societies and university partnerships.
Potential Concerns With aDecentralized Program
There have been some concerns vocalized by various government and
enforcement agencies regarding a decentralized program.
International Treaties: In the past, Health Canada has implied that
the decentralization of this program is restricted by our international treaty
obligations, the most significant of which are the Single Convention on Narcotic
Drugs [(1961)], the Convention on Psychotropic Substances [(1971)] and the
relevant portions of the United Nations Convention against Illicit Traffic in
Narcotic Drugs and Psychotropic Substances [(1988)].
Roadmap to Compassion
The Implementation of a WorkingMedicinal Cannabis Program in Canada
○ ○ ○ ○ ○ ○ ○ ○ ○○ ○ ○ ○ ○ ○ ○
11
According to section (c) of the original 1961 treaty, a signing country has the
right to produce any drug or substance so long as its use and distribution is:
“Subject to the provisions of this Convention, to limit exclusively to medical
and scientific purposes the production, manufacture, export, import,
distribution of, trade in, use and possession of drugs.” In other words, there
should be no doubt that the trade, use and possession of drugs for medical or
scientific purposes is permitted by the terms of this Convention.
Re-distribution: The fear of illicit re-distribution has been cited as a main
reason to maintain centralized federal control over the cultivation and
distribution of cannabis. No scientific data has ever been presented to suggest
that the re-distribution of cannabis would increase or be more of a concern than
it is under the current system. The same measures can be taken as are currently
in place for alcohol, cigarettes, or prescription and over-the-counter
pharmaceuticals.
The responsibility to dissuade the re-distribution of cannabis should fall on the
individual compassion societies. Currently the practice of compassion societies
includes clear and firm rules against diversion or re-distribution; memberships
have been revoked for the re-distribution of cannabis.
Increased Use: There may be a concern that legitimizing the compassion
societies would increase or promote the use of cannabis. Evidence from other
jurisdictions with medicinal cannabis programs would appear to counter this
claim. After the state of California passed medicinal cannabis legislation in 1996,
high school drug use surveys (conducted by the state every 2 years) have shown
that the rate of cannabis use has remained steady or has decreased2 .
Increased use is not necessarily a problem. Many people who need medicinal
cannabis are currently prevented from accessing the medicine they require.
What would undoubtedly result from the decentralization of this program would
be a visible shift by medicinal users away from black-market sources to licensed
distributors.
Timeline for Implementation
The relationship between Health Canada and the nation’s medicinal cannabis
users, cultivators and distributors has unfortunately suffered as a result of
broken promises, lengthy litigation, and a lack of cooperation and trust. We
are compelled to suggest a timeline for the implementation of these necessary
changes with the hope of allowing the government to fulfill its obligation in a
timely manner and to restore good faith between all parties.
Roadmap to Compassion
The Implementation of a WorkingMedicinal Cannabis Program in Canada
○ ○ ○ ○ ○ ○ ○ ○ ○○ ○ ○ ○ ○ ○ ○
12
3 months - The MMAR is changed to allow for the legal use of medicinal cannabis
with the diagnosis and recommendation of either a physician or other qualified
health care practitioner such as a Doctor of Traditional Chinese Medicine or
Naturopathic Doctor. Consultations with compassion societies and medicinal
users are initiated to produce a regulatory scheme for the community based,
not-for profit distribution of medicinal cannabis.
6 months - Licensing scheme is in place for compassion societies. Private
cultivators can bid for local, small-scale non-profit cultivation contracts from
Compassion Societies. Physician or health care practitioner diagnosis and
recommendation allows legal access to medicinal cannabis through compassion
societies.
9 months - Health Canada has expanded its research agenda and funding to
include compassion societies and university partnerships.
12 months - The program is fully decentralized. National standards in have
been collaboratively established for site inspections and the testing of cannabis
for strength and safety. Compassion societies are licensed.
Conclusion:
The future of a successful medicinal cannabis program in this country should
focus on the distribution model that has already proven itself to be safe and
successful: not-for profit distribution by community-based compassion societies.
For over seven years, national compassion clubs and societies have been risking
arrest and prosecution in order to address the pressing medicinal needs of
Canada’s critically and chronically ill, all at no cost to the taxpayer. This vital
work has been recognized by numerous Canadian courts, as well as governmental
bodies such as the Senate Special Committee on Illegal Drugs. Compassion
societies serve a clear and necessary purpose, and benefit from the support of
their local communities and of the Canadian public as a whole.
The decentralization of the Office of Cannabis Medical Access program and the
legitimization of these compassionate organizations will not only save Health Canada
both time and money, it will also address many of the concerns expressed by those
who could benefit from medicinal access to this herb. For the thousands of Canadians
who could alleviate their chronic and debilitating symptoms, while staying productive
and maintaining a level of hope and happiness despite their serious condition,
decentralization is simply the right thing for Health Canada to do.
1 http://thecompassionclub.org/club/standardsapr30.pdf
2 http://www.safestate.org/index.cfm?navID=254